Drug Trial Radar · NCT03742037
Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
Last checked: Nov 19, 2026Latest source record: Jul 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
427
Actual
Start
Dec 21, 2018
Primary completion
Aug 31, 2021
Study completion Aug 25, 2022
Sponsor
- Lead sponsor
- Viatris Innovation GmbHIndustry
- Sponsor type
- Industry
- First posted
- Nov 15, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to assess the efficacy and safety of 4 doses of cenerimod versus placebo in adult subjects with systemic lupus erythematosus (SLE).
Conditions
- Systemic Lupus Erythematosus
Interventions
Cenerimod 0.5 mgDrug
Cenerimod will be supplied as a film-coated tablets at the dose of 0.5 mg
Cenerimod 1 mgDrug
Cenerimod will be supplied as a film-coated tablets at the dose of 1 mg
Cenerimod 2 mgDrug
Cenerimod will be supplied as a film-coated tablets at the dose of 2 mg
Cenerimod 4 mgDrug
Cenerimod will be supplied as a film-coated tablets at the dose of 4 mg
PlaceboDrug
Matching placebo will be supplied as identical film-coated tablets formulated with the same excipients but without the active ingredient, cenerimod
cenerimod 2 mg (ex-4 mg)Drug
Cenerimod will be supplied as a film-coated tablets at the dose of 2 mg
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline to Month 6 in the Modified Systemic Lupus Erythematosus Activity Index 2000 (mSLEDAI-2K) ScoreTime frame: Baseline (Day 1) and Month 6
Locations
148 sites in 24 countries. Site status is shown where the registry gives one.
Pinnacle Research Group
Anniston, Alabama
University of California San Diego
La Jolla, California
Valerius Medical Group and Research Center
Los Alamitos, California
University of Colorado School of Medicine
Aurora, Colorado
Robert W Levin MD PA
Clearwater, Florida
Center for Rheumatology Immunology and Arthritis
Fort Lauderdale, Florida
Life Clinical Trials
Margate, Florida
D&H National Research Centers INC
Miami, Florida
San Marcus Research Clinic
Miami Lakes, Florida
Millennium Research
Ormond Beach, Florida
Integral Rheumatology & Immunology Specialists
Plantation, Florida
Advanced Research Institute Inc Allergy & Rheumatology
St. Petersburg, Florida
Axiom Clinical Research of Florida
Tampa, Florida
North Georgia Rheumatology Group - Duluth
Lawrenceville, Georgia
Institute of Arthritis Research
Idaho Falls, Idaho
Washington University School of Medicine
St Louis, Missouri
Innovative Health Research
Las Vegas, Nevada
New York Presbyterian Columbia University Medical Center
New York, New York
State University of New York Upstate Medical University
Syracuse, New York
Joint Muscle Medical Care and Research Institute - Lilington Office
Charlotte, North Carolina
DJL Clinical Research
Charlotte, North Carolina
Paramount Medical Research and Consulting
Middleburg Heights, Ohio
Altoona Center for Clinical Research
Duncansville, Pennsylvania
Office of Ramesh C. Gupta, MD
Memphis, Tennessee
Amarillo Center for Clinical Research
Amarillo, Texas
Accurate Clinical Research
Houston, Texas
Southwest Rheumatology Research, LLC
Mesquite, Texas
Sun Research Institute
San Antonio, Texas
Accurate Clinical Management
Stafford, Texas
University Multiprofile Hospital for Active Treatment Pulmed
Plovdiv, Bulgaria
Diagnostic and Consulting Center "Aleksandrovska" EOOD
Sofia, Bulgaria
Diagnostic Consulting Center Fokus-5
Sofia, Bulgaria
Multiprofile Hospital For Active Treatment Trimontium
Plovdiv, Plodiv, Bulgaria
Enroll SpA
Santiago, Chile
Biomedica Research Group
Santiago, Chile
Meditek Ltda.
Santiago, Chile
Prosalud
Santiago, Chile
Clinical Research Chile SpA
Valdivia, Chile
CCR Pardubice
Pardubice, Vychodocesky KRAJ, Czechia
Hôpital Haut-Lévêque
Pessac, France
Showing 40 of 148 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.